source
- FDA approves first generic single-dose baloxavir tablet for flu treatment and preventionFDA announced approval of the first generic version of Xofluza (baloxavir marboxil) tablets, a single-dose treatment for acute uncomplicated influenza and prophylaxis for patients five years of age…
- Triveni Bio secures $65M Series C as second eczema candidate enters clinical trialsTriveni Bio announced a $65 million Series C financing round aimed at supporting its ongoing development programs. The round was co‑led by Ascenta Capital and Janus Henderson Investors, with parti…